Descriptor English: | Alloxan | ||||
Descriptor Spanish: |
Aloxano
| ||||
Descriptor Portuguese: | Aloxano | ||||
Descriptor French: | Alloxane | ||||
Tree number(s): |
D03.383.742.698.122 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000496 | ||||
Scope note: | Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate. |
||||
Annotation: | for ALLOXAN DIABETES, index ALLOXAN only if the chemical is particularly discussed |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Registry Number: | 6SW5YHA5NG | ||||
CAS Type 1 Name: | 2,4,5,6(1H,3H)-Pyrimidinetetrone | ||||
DeCS ID: | 499 | ||||
Unique ID: | D000496 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2017/06/19 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Alloxan
- Preferred
Concept UI |
M0000748 |
Scope note | Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate. |
Preferred term | Alloxan |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey